RECALL: Vecuronium Bromide Injection Recall

Bedford Laboratories announced a voluntary recall of Vecuronium Bromide Injection Preservative-Free due to the discovery of potentially hazardous material in a small number of vials during a post-release inspection.

Potential adverse reactions may include vein irritation and phlebitis, occult pulmonary granulomas, local tissue infarction, severe pulmonary dysfunction, occlusion of capillaries and arteries, and anaphylactic shock and death.

The affected 20mg vials contain NDC #55390-039-10 and Lot# 2067134 with an expiration date of 5/31/2013.  The company stated that the first shipment was on 8/8/2011, and the last shipment was on 11/9/2011.

Vecuronium Bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

For more information call (800) 521-5169 or visit www.BedfordLabs.com.